CHENGDU, China, Feb. 6, 2026 -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that a new indication application for its TROP2-directed ADC sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) has been approved by the National Medical Products Administration (NMPA) of China for treatment of adult patients with unresectable or metastatic HR+/HER2- (IHC 0, IHC 1+ or IHC 2+/ISH-) breast cancer (BC) who have received prior endocrine therapy (ET) and at least one line of chemotherapy in advan
[ 메디채널 황정호 기자 ] Ferrero Group maintains its growth trajectory with a 4.6% increase in turnover to EUR 19.3 billion. Strategy of innovation, portfolio expansion and acquisitions drove continued success in 2024/25. Platform for future growth further supported by increased capital investment of close to EUR 1.1 billion in 2024/25 and the acquisition of WK Kellogg Co. which closed in September 2025[1]. LUXEMBOURG, Feb. 6, 2026 -- The Ferrero Group, through its holding company Ferrero International S.A., approved the Consolidated Financial Statements for the 2024/2025 financial year
SHANGHAI, Feb. 6, 2026 -- A news report from english.shanghai.gov.cn Tori Cignarella from New York checks out travel, work and settlement information about Shanghai after watching the "Live Your Shanghai" video on the Nasdaq screen in Times Square on Feb 2. New Yorkers received a digital greeting from Shanghai this week as the city's vibrant energy lit up one of the world's most iconic screens. The Nasdaq screen in Times Square broadcast a special video produced by International Services Shanghai, showcasing dynamic street scenes and everyday life in Sha
SINGAPORE, Feb. 6, 2026 -- Following the global success of its European and American editions, CYSAT Asia concluded its first-ever regional event in Singapore yesterday. Co-organised by SGInnovate and the European cybersecurity leader CYSEC, the event gathered 400 participants, global experts, government officials, and industry pioneers from 25 European and Asian countries to address the urgent need for resilient space infrastructure. The event convened leading voices from across the space tech and cybersecurity sectors to discuss the why's and how's of securing space assets, the impac
SHENZHEN, China, Feb. 6, 2026 -- MANCHESTER CITY AND UNILUMIN, a world-leading provider of LED display, lighting products and integrated Metasight solutions, announced a new partnership on January 22, 2026. The new multi-year agreement will see Unilumin integrated within the Club's new entertainment destination. Unilumin will provide large-scale LED screens that will sit on the ends of the new development, in addition to a large screen in the fan zone area that will be utilised for match days and beyond. In September 2022, Unilumin previously provided a 'Supersize
[ 메디채널 김갑성 기자 ] New clinical evidence highlights a smarter, technology-driven approach to scar management, rejuvenation, and tattoo removal HONG KONG, Feb. 6, 2026 -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, today announced that its core subsidiary, Alma, the Group's Energy-Based Devices (EBD) brand, featured its vision for the future of Intelligent Aesthetics
HONG KONG, Feb. 6, 2026 -- On February 6th, 2026, Muyuan Foods Co., Ltd. ("Muyuan Foods" or the "Company", Stock Code: 02714.HK), a global leader in the pig farming industry, was officially listed on the Stock Exchange of Hong Kong Limited, becoming the first pig farming enterprise with "A+H" dual-listing in China. Assuming the Over-allotment Option is fully exercised, the net proceeds from this offering will be up to HK$12.038 billion. This would be the world's largest IPO of agricultural and animal husbandry enterprises since 2026, and one of the largest agricu
TCL Edelweiss Land launches at Milan Central Station, showcasing innovation in the heart of the city MILAN, Feb. 6, 2026 -- TCL, a leading global technology company and a Worldwide Olympic and Paralympic Partner, celebrated the opening of the Olympic Winter Games Milano Cortina 2026 with the launch of its "It's Your Greatness" campaign and the inauguration of its creative showcase, TCL Edelweiss Land, at the Piazza Duca d'Aosta in front of Milan Central Station. Key guests attended the opening on 5 February, including Kirsty Coventry, President of the International Ol
[ 메디채널 김장윤(JASON KIM) 기자 ] 싱가포르, 2026년 2월 6일 -- 아시아 엔터테인먼트의 중심 아이치이(iQIYI)가 전설적인 대형 프로젝트인 아이치이 오리지널 예능 프로그램 '런닝맨 태국(Running Man Thailand)'을 공식 공개하며 전 세계 엔터테인먼트 시장에 강렬한 파장을 예고했다. 이번 기대작의 공개를 기념해 진행된 단독 기자 간담회에는 프로그램의 핵심 '에이전트'인 오트 프라모트(Oat Pramote), 다우 피타야(Daou Pittaya), 누뉴 차와린(NuNew Chawarin)이 참석해 고강도의 제작 과정과 비하인드 스토리를 전했다. 또한 아이치이 태국 공동대표 코코 양(Koko Yang)도 스리나카린위롯 대학교(프라산밋 캠퍼스) 미디어•교육기술청에서 열린 행사에 함께했다. 한국에서 시작된 원작 포맷의 폭발적인 성공과 중국, 필리핀, 베트남 등에서의 호평을 받은 현지화 버전에 이어, 런닝맨 프랜차이즈가 2026년 공식적으로 태국에 상륙한다. 이번 태국판은 전 세계 팬들에게 특유의 '배꼽 잡는 유머와 심장을 뛰게 하는 액션'을 그대로 선사할 예정이다. 아이치이 오리지널 '런
SEONGNAM, South Korea, Feb. 6, 2026 -- PharmaResearch Co., Ltd. (CEO: Jihoon Sohn) today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for PRD-101, enabling the initiation of a Phase 1 clinical trial in the United States. PRD-101 is a next-generation nano anticancer drug candidate formulated using nucleotide fragments produced through PharmaResearch's proprietary DOT® (DNA Optimizing Technology). The drug leverages the company's nucleotide-based Advanced DOT™ drug delivery platform, designed to